In the past decades, synthetic biology has gained interest regarding research and development efforts within the biotechnology domain. However, it is unclear to what extent synthetic biology has matured already into being commercially exploitable. By means of a patent analysis, this study shows that there is an increasing trend regarding synthetic biology related patent applications. The majority of retrieved patents relates to innovations facilitating the realisation of synthetic biology through improved understanding of biological systems. In addition, there is increased activity concerning the development of synthetic biology based applications. When looking at potential application areas, the majority of synthetic biology patents seems most relevant for the medical, energy and industrial sector. Furthermore, the analysis shows that most activity has been carried out by the USA, with Japan and a number of European countries considerably trailing behind. In addition, both universities and companies are major patent applicant actor types. The results presented here form a starting point for follow-up studies concerning the identification of drivers explaining the observed patent application trends in synthetic biology.
Electronic supplementary materialThe online version of this article (doi:10.1007/s11693-013-9121-7) contains supplementary material, which is available to authorized users.
Desorptive capacity is the organisational ability to transfer internal knowledge to external actors to obtain competitive advantage. We distinguish two forms of desorptive capacity to investigate how organisations active in emerging technology domains explore and exploit opportunities to match internally developed technology to external needs. We also focus on management innovationthe ability to create or revise organisational structures or processesas a potential antecedent of desorptive capacity. From a study of 84 synthetic biology organisations we found that explorative and exploitative desorptive capacity mediate the relationship between management innovation and external technology commercialisation.The study provides empirical evidence of the existence and interdependence of different managerial and organisational processes required for external technology commercialisation. We underscore how organisations can valorise technological assets strategically through management innovation and by achieving a fit between internal practices and the technological base of potential technology adopters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.